Empowering Patients with Rheumatic Diseases: The KOMO-R Randomized Controlled Trial on Adherence to Preventative Health Measures

Empowering Patients with Rheumatic Diseases: The KOMO-R Randomized Controlled Trial on Adherence to Preventative Health Measures - KOMO-R

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00034872

Enrollment

200

Registered

2024-08-15

Start date

2023-07-26

Completion date

Unknown

Last updated

2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

autoimmune inflammatory rheumatic diseases

Interventions

Group 1: Control: Personalized to-do lists of up to 14 preventive health tasks based on age, gender, and previous adherence Group 2: Intervention: Personalized to-do lists of up to 14 preventive healt

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Patients with inflammatory rheumatic diseases - Willingness and ability to participate in the study, sufficient knowledge of German to understand the informed consent form - High probability that the patients will be able to participate in the full duration of the study - A signed informed consent form is required for all subjects to participate in this study

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Number of to-do list items completed	—

Secondary

Measure	Time frame
Vaccination rates and cancer screening adherence	—

Countries

Germany

Contacts

Public ContactAxel Hueber

Klinikum Nürnberg, Abteilung Rheumatologie

rheumatologie@klinikum-nuernberg.de+49 (0) 911 398-3052

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026